Genetic Disease Diagnostic Industry Research Report 2023
Highlights
The global Genetic Disease Diagnostic market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Genetic Disease Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Genetic Disease Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Genetic Disease Diagnostic include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd. and Illumina, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Genetic Disease Diagnostic in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Prenatal Diagnosis, which accounted for % of the global market of Genetic Disease Diagnostic in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genetic Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Disease Diagnostic.
The Genetic Disease Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genetic Disease Diagnostic market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Genetic Disease Diagnostic type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Genetic Disease Diagnostic are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Genetic Disease Diagnostic segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Genetic Disease Diagnostic market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Genetic Disease Diagnostic market.
Genetic Disease Diagnostic Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Genetic Disease Diagnostic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Disease Diagnostic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Genetic Disease Diagnostic and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Genetic Disease Diagnostic industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Disease Diagnostic.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Genetic Disease Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
The global Genetic Disease Diagnostic market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Genetic Disease Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Genetic Disease Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Genetic Disease Diagnostic include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd. and Illumina, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Genetic Disease Diagnostic in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Prenatal Diagnosis, which accounted for % of the global market of Genetic Disease Diagnostic in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genetic Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Disease Diagnostic.
The Genetic Disease Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genetic Disease Diagnostic market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Abbott
- PerkinElmer
- Roche Diagnostics
- Bio Rad
- Thermo Fisher Scientific
- BGI Group
- Berry Genomics
- Da An Gene Co., Ltd.
- Illumina
- CapitalBio Technology
Global markets are presented by Genetic Disease Diagnostic type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Genetic Disease Diagnostic are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Genetic Disease Diagnostic segment by Type
- Prenatal Diagnosis
- Screening for Single Gene Genetic Disease
- Preimplantation Genetic Testing
- Others
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Genetic Disease Diagnostic market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Genetic Disease Diagnostic market.
Genetic Disease Diagnostic Segment by Application
- Hospital
- Medical Laboratory
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Genetic Disease Diagnostic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Disease Diagnostic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Genetic Disease Diagnostic and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Genetic Disease Diagnostic industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Disease Diagnostic.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Genetic Disease Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Genetic Disease Diagnostic by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Prenatal Diagnosis
1.2.3 Screening for Single Gene Genetic Disease
1.2.4 Preimplantation Genetic Testing
1.2.5 Others
2.3 Genetic Disease Diagnostic by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Hospital
2.3.3 Medical Laboratory
2.3.4 Others
2.4 Assumptions and Limitations
3 GENETIC DISEASE DIAGNOSTIC BREAKDOWN DATA BY TYPE
3.1 Global Genetic Disease Diagnostic Historic Market Size by Type (2018-2023)
3.2 Global Genetic Disease Diagnostic Forecasted Market Size by Type (2023-2028)
4 GENETIC DISEASE DIAGNOSTIC BREAKDOWN DATA BY APPLICATION
4.1 Global Genetic Disease Diagnostic Historic Market Size by Application (2018-2023)
4.2 Global Genetic Disease Diagnostic Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Genetic Disease Diagnostic Market Perspective (2018-2029)
5.2 Global Genetic Disease Diagnostic Growth Trends by Region
5.2.1 Global Genetic Disease Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Genetic Disease Diagnostic Historic Market Size by Region (2018-2023)
5.2.3 Genetic Disease Diagnostic Forecasted Market Size by Region (2024-2029)
5.3 Genetic Disease Diagnostic Market Dynamics
5.3.1 Genetic Disease Diagnostic Industry Trends
5.3.2 Genetic Disease Diagnostic Market Drivers
5.3.3 Genetic Disease Diagnostic Market Challenges
5.3.4 Genetic Disease Diagnostic Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Genetic Disease Diagnostic Players by Revenue
6.1.1 Global Top Genetic Disease Diagnostic Players by Revenue (2018-2023)
6.1.2 Global Genetic Disease Diagnostic Revenue Market Share by Players (2018-2023)
6.2 Global Genetic Disease Diagnostic Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Genetic Disease Diagnostic Head office and Area Served
6.4 Global Genetic Disease Diagnostic Players, Product Type & Application
6.5 Global Genetic Disease Diagnostic Players, Date of Enter into This Industry
6.6 Global Genetic Disease Diagnostic Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Genetic Disease Diagnostic Market Size (2018-2029)
7.2 North America Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Genetic Disease Diagnostic Market Size by Country (2018-2023)
7.4 North America Genetic Disease Diagnostic Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Genetic Disease Diagnostic Market Size (2018-2029)
8.2 Europe Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Genetic Disease Diagnostic Market Size by Country (2018-2023)
8.4 Europe Genetic Disease Diagnostic Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Genetic Disease Diagnostic Market Size (2018-2029)
9.2 Asia-Pacific Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Genetic Disease Diagnostic Market Size by Country (2018-2023)
9.4 Asia-Pacific Genetic Disease Diagnostic Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Genetic Disease Diagnostic Market Size (2018-2029)
10.2 Latin America Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Genetic Disease Diagnostic Market Size by Country (2018-2023)
10.4 Latin America Genetic Disease Diagnostic Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Genetic Disease Diagnostic Market Size (2018-2029)
11.2 Middle East & Africa Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2018-2023)
11.4 Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Genetic Disease Diagnostic Introduction
11.1.4 Abbott Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.1.5 Abbott Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Detail
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Genetic Disease Diagnostic Introduction
11.2.4 PerkinElmer Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.2.5 PerkinElmer Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Detail
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Genetic Disease Diagnostic Introduction
11.3.4 Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.3.5 Roche Diagnostics Recent Development
11.4 Bio Rad
11.4.1 Bio Rad Company Detail
11.4.2 Bio Rad Business Overview
11.4.3 Bio Rad Genetic Disease Diagnostic Introduction
11.4.4 Bio Rad Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.4.5 Bio Rad Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Introduction
11.5.4 Thermo Fisher Scientific Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 BGI Group
11.6.1 BGI Group Company Detail
11.6.2 BGI Group Business Overview
11.6.3 BGI Group Genetic Disease Diagnostic Introduction
11.6.4 BGI Group Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.6.5 BGI Group Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Detail
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Genetic Disease Diagnostic Introduction
11.7.4 Berry Genomics Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.7.5 Berry Genomics Recent Development
11.8 Da An Gene Co., Ltd.
11.8.1 Da An Gene Co., Ltd. Company Detail
11.8.2 Da An Gene Co., Ltd. Business Overview
11.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Introduction
11.8.4 Da An Gene Co., Ltd. Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.8.5 Da An Gene Co., Ltd. Recent Development
11.9 Illumina
11.9.1 Illumina Company Detail
11.9.2 Illumina Business Overview
11.9.3 Illumina Genetic Disease Diagnostic Introduction
11.9.4 Illumina Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.9.5 Illumina Recent Development
11.10 CapitalBio Technology
11.10.1 CapitalBio Technology Company Detail
11.10.2 CapitalBio Technology Business Overview
11.10.3 CapitalBio Technology Genetic Disease Diagnostic Introduction
11.10.4 CapitalBio Technology Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.10.5 CapitalBio Technology Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Genetic Disease Diagnostic by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Prenatal Diagnosis
1.2.3 Screening for Single Gene Genetic Disease
1.2.4 Preimplantation Genetic Testing
1.2.5 Others
2.3 Genetic Disease Diagnostic by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Hospital
2.3.3 Medical Laboratory
2.3.4 Others
2.4 Assumptions and Limitations
3 GENETIC DISEASE DIAGNOSTIC BREAKDOWN DATA BY TYPE
3.1 Global Genetic Disease Diagnostic Historic Market Size by Type (2018-2023)
3.2 Global Genetic Disease Diagnostic Forecasted Market Size by Type (2023-2028)
4 GENETIC DISEASE DIAGNOSTIC BREAKDOWN DATA BY APPLICATION
4.1 Global Genetic Disease Diagnostic Historic Market Size by Application (2018-2023)
4.2 Global Genetic Disease Diagnostic Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Genetic Disease Diagnostic Market Perspective (2018-2029)
5.2 Global Genetic Disease Diagnostic Growth Trends by Region
5.2.1 Global Genetic Disease Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Genetic Disease Diagnostic Historic Market Size by Region (2018-2023)
5.2.3 Genetic Disease Diagnostic Forecasted Market Size by Region (2024-2029)
5.3 Genetic Disease Diagnostic Market Dynamics
5.3.1 Genetic Disease Diagnostic Industry Trends
5.3.2 Genetic Disease Diagnostic Market Drivers
5.3.3 Genetic Disease Diagnostic Market Challenges
5.3.4 Genetic Disease Diagnostic Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Genetic Disease Diagnostic Players by Revenue
6.1.1 Global Top Genetic Disease Diagnostic Players by Revenue (2018-2023)
6.1.2 Global Genetic Disease Diagnostic Revenue Market Share by Players (2018-2023)
6.2 Global Genetic Disease Diagnostic Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Genetic Disease Diagnostic Head office and Area Served
6.4 Global Genetic Disease Diagnostic Players, Product Type & Application
6.5 Global Genetic Disease Diagnostic Players, Date of Enter into This Industry
6.6 Global Genetic Disease Diagnostic Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Genetic Disease Diagnostic Market Size (2018-2029)
7.2 North America Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Genetic Disease Diagnostic Market Size by Country (2018-2023)
7.4 North America Genetic Disease Diagnostic Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Genetic Disease Diagnostic Market Size (2018-2029)
8.2 Europe Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Genetic Disease Diagnostic Market Size by Country (2018-2023)
8.4 Europe Genetic Disease Diagnostic Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Genetic Disease Diagnostic Market Size (2018-2029)
9.2 Asia-Pacific Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Genetic Disease Diagnostic Market Size by Country (2018-2023)
9.4 Asia-Pacific Genetic Disease Diagnostic Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Genetic Disease Diagnostic Market Size (2018-2029)
10.2 Latin America Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Genetic Disease Diagnostic Market Size by Country (2018-2023)
10.4 Latin America Genetic Disease Diagnostic Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Genetic Disease Diagnostic Market Size (2018-2029)
11.2 Middle East & Africa Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2018-2023)
11.4 Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Genetic Disease Diagnostic Introduction
11.1.4 Abbott Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.1.5 Abbott Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Detail
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Genetic Disease Diagnostic Introduction
11.2.4 PerkinElmer Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.2.5 PerkinElmer Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Detail
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Genetic Disease Diagnostic Introduction
11.3.4 Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.3.5 Roche Diagnostics Recent Development
11.4 Bio Rad
11.4.1 Bio Rad Company Detail
11.4.2 Bio Rad Business Overview
11.4.3 Bio Rad Genetic Disease Diagnostic Introduction
11.4.4 Bio Rad Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.4.5 Bio Rad Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Introduction
11.5.4 Thermo Fisher Scientific Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 BGI Group
11.6.1 BGI Group Company Detail
11.6.2 BGI Group Business Overview
11.6.3 BGI Group Genetic Disease Diagnostic Introduction
11.6.4 BGI Group Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.6.5 BGI Group Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Detail
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Genetic Disease Diagnostic Introduction
11.7.4 Berry Genomics Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.7.5 Berry Genomics Recent Development
11.8 Da An Gene Co., Ltd.
11.8.1 Da An Gene Co., Ltd. Company Detail
11.8.2 Da An Gene Co., Ltd. Business Overview
11.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Introduction
11.8.4 Da An Gene Co., Ltd. Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.8.5 Da An Gene Co., Ltd. Recent Development
11.9 Illumina
11.9.1 Illumina Company Detail
11.9.2 Illumina Business Overview
11.9.3 Illumina Genetic Disease Diagnostic Introduction
11.9.4 Illumina Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.9.5 Illumina Recent Development
11.10 CapitalBio Technology
11.10.1 CapitalBio Technology Company Detail
11.10.2 CapitalBio Technology Business Overview
11.10.3 CapitalBio Technology Genetic Disease Diagnostic Introduction
11.10.4 CapitalBio Technology Revenue in Genetic Disease Diagnostic Business (2017-2022)
11.10.5 CapitalBio Technology Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Genetic Disease Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Genetic Disease Diagnostic Revenue Market Share by Type (2018-2023)
Table 7. Global Genetic Disease Diagnostic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Genetic Disease Diagnostic Revenue Market Share by Type (2024-2029)
Table 9. Global Genetic Disease Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Genetic Disease Diagnostic Revenue Market Share by Application (2018-2023)
Table 11. Global Genetic Disease Diagnostic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Genetic Disease Diagnostic Revenue Market Share by Application (2024-2029)
Table 13. Global Genetic Disease Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Genetic Disease Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Genetic Disease Diagnostic Market Share by Region (2018-2023)
Table 16. Global Genetic Disease Diagnostic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Genetic Disease Diagnostic Market Share by Region (2024-2029)
Table 18. Genetic Disease Diagnostic Market Trends
Table 19. Genetic Disease Diagnostic Market Drivers
Table 20. Genetic Disease Diagnostic Market Challenges
Table 21. Genetic Disease Diagnostic Market Restraints
Table 22. Global Top Genetic Disease Diagnostic Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Genetic Disease Diagnostic Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Genetic Disease Diagnostic Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Genetic Disease Diagnostic, Headquarters and Area Served
Table 26. Global Genetic Disease Diagnostic Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Genetic Disease Diagnostic by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Genetic Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Genetic Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Genetic Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Genetic Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 45. Abbott Company Detail
Table 46. Abbott Business Overview
Table 47. Abbott Genetic Disease Diagnostic Product
Table 48. Abbott Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 49. Abbott Recent Development
Table 50. PerkinElmer Company Detail
Table 51. PerkinElmer Business Overview
Table 52. PerkinElmer Genetic Disease Diagnostic Product
Table 53. PerkinElmer Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 54. PerkinElmer Recent Development
Table 55. Roche Diagnostics Company Detail
Table 56. Roche Diagnostics Business Overview
Table 57. Roche Diagnostics Genetic Disease Diagnostic Product
Table 58. Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 59. Roche Diagnostics Recent Development
Table 60. Bio Rad Company Detail
Table 61. Bio Rad Business Overview
Table 62. Bio Rad Genetic Disease Diagnostic Product
Table 63. Bio Rad Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 64. Bio Rad Recent Development
Table 65. Thermo Fisher Scientific Company Detail
Table 66. Thermo Fisher Scientific Business Overview
Table 67. Thermo Fisher Scientific Genetic Disease Diagnostic Product
Table 68. Thermo Fisher Scientific Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 69. Thermo Fisher Scientific Recent Development
Table 70. BGI Group Company Detail
Table 71. BGI Group Business Overview
Table 72. BGI Group Genetic Disease Diagnostic Product
Table 73. BGI Group Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 74. BGI Group Recent Development
Table 75. Berry Genomics Company Detail
Table 76. Berry Genomics Business Overview
Table 77. Berry Genomics Genetic Disease Diagnostic Product
Table 78. Berry Genomics Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 79. Berry Genomics Recent Development
Table 80. Da An Gene Co., Ltd. Company Detail
Table 81. Da An Gene Co., Ltd. Business Overview
Table 82. Da An Gene Co., Ltd. Genetic Disease Diagnostic Product
Table 83. Da An Gene Co., Ltd. Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 84. Da An Gene Co., Ltd. Recent Development
Table 85. Illumina Company Detail
Table 86. Illumina Business Overview
Table 87. Illumina Genetic Disease Diagnostic Product
Table 88. Illumina Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 89. Illumina Recent Development
Table 90. CapitalBio Technology Company Detail
Table 91. CapitalBio Technology Business Overview
Table 92. CapitalBio Technology Genetic Disease Diagnostic Product
Table 93. CapitalBio Technology Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 94. CapitalBio Technology Recent Development
Table 95. Abbott Company Information
Table 96. Abbott Business Overview
Table 97. Abbott Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 98. Abbott Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 99. Abbott Recent Development
Table 100. PerkinElmer Company Information
Table 101. PerkinElmer Business Overview
Table 102. PerkinElmer Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 103. PerkinElmer Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 104. PerkinElmer Recent Development
Table 105. Roche Diagnostics Company Information
Table 106. Roche Diagnostics Business Overview
Table 107. Roche Diagnostics Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 108. Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 109. Roche Diagnostics Recent Development
Table 110. Bio Rad Company Information
Table 111. Bio Rad Business Overview
Table 112. Bio Rad Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 113. Bio Rad Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 114. Bio Rad Recent Development
Table 115. Thermo Fisher Scientific Company Information
Table 116. Thermo Fisher Scientific Business Overview
Table 117. Thermo Fisher Scientific Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 118. Thermo Fisher Scientific Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 119. Thermo Fisher Scientific Recent Development
Table 120. BGI Group Company Information
Table 121. BGI Group Business Overview
Table 122. BGI Group Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 123. BGI Group Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 124. BGI Group Recent Development
Table 125. Berry Genomics Company Information
Table 126. Berry Genomics Business Overview
Table 127. Berry Genomics Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 128. Berry Genomics Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 129. Berry Genomics Recent Development
Table 130. Da An Gene Co., Ltd. Company Information
Table 131. Da An Gene Co., Ltd. Business Overview
Table 132. Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 133. Da An Gene Co., Ltd. Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 134. Da An Gene Co., Ltd. Recent Development
Table 135. Illumina Company Information
Table 136. Illumina Business Overview
Table 137. Illumina Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 138. Illumina Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 139. Illumina Recent Development
Table 140. CapitalBio Technology Company Information
Table 141. CapitalBio Technology Business Overview
Table 142. CapitalBio Technology Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 143. CapitalBio Technology Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Genetic Disease Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Genetic Disease Diagnostic Revenue Market Share by Type (2018-2023)
Table 7. Global Genetic Disease Diagnostic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Genetic Disease Diagnostic Revenue Market Share by Type (2024-2029)
Table 9. Global Genetic Disease Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Genetic Disease Diagnostic Revenue Market Share by Application (2018-2023)
Table 11. Global Genetic Disease Diagnostic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Genetic Disease Diagnostic Revenue Market Share by Application (2024-2029)
Table 13. Global Genetic Disease Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Genetic Disease Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Genetic Disease Diagnostic Market Share by Region (2018-2023)
Table 16. Global Genetic Disease Diagnostic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Genetic Disease Diagnostic Market Share by Region (2024-2029)
Table 18. Genetic Disease Diagnostic Market Trends
Table 19. Genetic Disease Diagnostic Market Drivers
Table 20. Genetic Disease Diagnostic Market Challenges
Table 21. Genetic Disease Diagnostic Market Restraints
Table 22. Global Top Genetic Disease Diagnostic Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Genetic Disease Diagnostic Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Genetic Disease Diagnostic Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Genetic Disease Diagnostic, Headquarters and Area Served
Table 26. Global Genetic Disease Diagnostic Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Genetic Disease Diagnostic by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Genetic Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Genetic Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Genetic Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Genetic Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Genetic Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Genetic Disease Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 45. Abbott Company Detail
Table 46. Abbott Business Overview
Table 47. Abbott Genetic Disease Diagnostic Product
Table 48. Abbott Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 49. Abbott Recent Development
Table 50. PerkinElmer Company Detail
Table 51. PerkinElmer Business Overview
Table 52. PerkinElmer Genetic Disease Diagnostic Product
Table 53. PerkinElmer Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 54. PerkinElmer Recent Development
Table 55. Roche Diagnostics Company Detail
Table 56. Roche Diagnostics Business Overview
Table 57. Roche Diagnostics Genetic Disease Diagnostic Product
Table 58. Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 59. Roche Diagnostics Recent Development
Table 60. Bio Rad Company Detail
Table 61. Bio Rad Business Overview
Table 62. Bio Rad Genetic Disease Diagnostic Product
Table 63. Bio Rad Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 64. Bio Rad Recent Development
Table 65. Thermo Fisher Scientific Company Detail
Table 66. Thermo Fisher Scientific Business Overview
Table 67. Thermo Fisher Scientific Genetic Disease Diagnostic Product
Table 68. Thermo Fisher Scientific Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 69. Thermo Fisher Scientific Recent Development
Table 70. BGI Group Company Detail
Table 71. BGI Group Business Overview
Table 72. BGI Group Genetic Disease Diagnostic Product
Table 73. BGI Group Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 74. BGI Group Recent Development
Table 75. Berry Genomics Company Detail
Table 76. Berry Genomics Business Overview
Table 77. Berry Genomics Genetic Disease Diagnostic Product
Table 78. Berry Genomics Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 79. Berry Genomics Recent Development
Table 80. Da An Gene Co., Ltd. Company Detail
Table 81. Da An Gene Co., Ltd. Business Overview
Table 82. Da An Gene Co., Ltd. Genetic Disease Diagnostic Product
Table 83. Da An Gene Co., Ltd. Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 84. Da An Gene Co., Ltd. Recent Development
Table 85. Illumina Company Detail
Table 86. Illumina Business Overview
Table 87. Illumina Genetic Disease Diagnostic Product
Table 88. Illumina Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 89. Illumina Recent Development
Table 90. CapitalBio Technology Company Detail
Table 91. CapitalBio Technology Business Overview
Table 92. CapitalBio Technology Genetic Disease Diagnostic Product
Table 93. CapitalBio Technology Revenue in Genetic Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 94. CapitalBio Technology Recent Development
Table 95. Abbott Company Information
Table 96. Abbott Business Overview
Table 97. Abbott Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 98. Abbott Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 99. Abbott Recent Development
Table 100. PerkinElmer Company Information
Table 101. PerkinElmer Business Overview
Table 102. PerkinElmer Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 103. PerkinElmer Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 104. PerkinElmer Recent Development
Table 105. Roche Diagnostics Company Information
Table 106. Roche Diagnostics Business Overview
Table 107. Roche Diagnostics Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 108. Roche Diagnostics Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 109. Roche Diagnostics Recent Development
Table 110. Bio Rad Company Information
Table 111. Bio Rad Business Overview
Table 112. Bio Rad Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 113. Bio Rad Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 114. Bio Rad Recent Development
Table 115. Thermo Fisher Scientific Company Information
Table 116. Thermo Fisher Scientific Business Overview
Table 117. Thermo Fisher Scientific Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 118. Thermo Fisher Scientific Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 119. Thermo Fisher Scientific Recent Development
Table 120. BGI Group Company Information
Table 121. BGI Group Business Overview
Table 122. BGI Group Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 123. BGI Group Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 124. BGI Group Recent Development
Table 125. Berry Genomics Company Information
Table 126. Berry Genomics Business Overview
Table 127. Berry Genomics Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 128. Berry Genomics Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 129. Berry Genomics Recent Development
Table 130. Da An Gene Co., Ltd. Company Information
Table 131. Da An Gene Co., Ltd. Business Overview
Table 132. Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 133. Da An Gene Co., Ltd. Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 134. Da An Gene Co., Ltd. Recent Development
Table 135. Illumina Company Information
Table 136. Illumina Business Overview
Table 137. Illumina Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 138. Illumina Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
Table 139. Illumina Recent Development
Table 140. CapitalBio Technology Company Information
Table 141. CapitalBio Technology Business Overview
Table 142. CapitalBio Technology Genetic Disease Diagnostic Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million)
Table 143. CapitalBio Technology Revenue in Genetic Disease Diagnostic Business (2018-2023) & (US$ Million) Portfolio
